Zimmer Biomet Holdings (ZBH) Gains from Investment Securities (2009 - 2026)

Zimmer Biomet Holdings' Gains from Investment Securities history runs 18 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 1966.67% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.9 million (down 44.35% YoY), while the FY2024 annual figure was $5.4 million, down 13.66% from the prior year.
• Gains from Investment Securities was $6.2 million for Q1 2026 at Zimmer Biomet Holdings, up from -$2.8 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $66.0 million in Q2 2023 to a low of -$73.3 million in Q3 2023.
• Historically, Gains from Investment Securities has averaged $2.4 million across 5 years, with a median of $1.0 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities soared 11800.0% in 2022, then tumbled 2081.08% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at -$43.7 million in 2022, then jumped by 50.11% to -$21.8 million in 2023, then jumped by 87.16% to -$2.8 million in 2024, then changed by 0.0% to -$2.8 million in 2025, then surged by 321.43% to $6.2 million in 2026.
• The last three Gains from Investment Securities figures came in at $6.2 million (Q1 2026), -$2.8 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.